I've led global clinical trial operations across phases 1–4 and multiple therapeutic areas, including oncology, hematology, immunology, dermatology, ophthalmology, and rare diseases.
At Syneos Health, supporting AbbVie and Pfizer, I directed cross-functional study teams, managed CROs and third-party vendors, maintained audit-ready Trial Master Files, and tracked site activation, enrollment, monitoring, and data quality.
At ICON/PRA, I managed a Phase 1 oncology dose-escalation trial, increased enrollment to 80% by opening three EU sites, and completed the study ahead of deadline. I also improved clinical systems and reduced out-of-scope resource demands by 80%.
As Senior Director of Clinical Operations at Therapeutics, Inc., I supervised 24 direct reports, supported eight dermatology studies, and helped achieve an FDA inspection with no findings and PAS approval. I build compliant, practical processes that protect trial integrity while moving studies forward.
